(2020 Service Council) Observation of Service Council: How important is international anti-epidemic cooperation as the global epidemic is spreading?
China News Service, Beijing, September 8th (Reporter Du Yan) As the first major international economic and trade event held offline in China since the outbreak of the new crown pneumonia epidemic, the 2020 China International Trade in Services Fair is being held in Beijing to set up a special public health and anti-epidemic event. The special exhibition area displays more than 100 domestic and foreign companies' scientific and technological anti-epidemic products and technological achievements.
Data map: On September 5, the staff displayed the new coronavirus inactivated vaccine antigen 3D model and the new coronavirus inactivated vaccine in the comprehensive exhibition area of the 2020 Service and Trade Fair.
Photo by China News Agency reporter Zhang Xinglong
China hopes to build a platform and bridge to discuss the creation of fair and accessible global health public products and promote the global fight against the epidemic.
At present, the new crown pneumonia epidemic is still spreading around the world, and the vaccines that people in all countries are looking forward to are on the market, and international cooperation is inseparable.
In the public health and epidemic prevention special exhibition area, two Chinese companies adjacent to the two booths displayed the latest research and development of the new coronavirus vaccine, which was "preferred" by the public and industry professionals as the "net celebrity" in the exhibition area.
"The vaccine phase III clinical trials being advanced are a model of international cooperation in the anti-epidemic process." Zhang Yuntao, vice president of Sinopharm Group China Biotechnology Co., Ltd., said that the company is currently carrying out phase three in 10 countries including the UAE, Peru, Morocco, and Pakistan. In clinical research, nearly 50,000 people have been enrolled in the group, hoping that the vaccine can contribute to the health of all mankind.
Compared with traditional vaccine development, the development of new crown vaccines is much faster.
Yin Weidong, chairman of Kexing Holding Biotechnology Co., Ltd., said that the company has successively launched phase three clinical trials in Brazil, Indonesia and other countries. The vaccine is expected to be launched by the end of this year, and priority will be given to listing in countries and regions without vaccine research and development capabilities and supply.
The innovation, production and application of the latest anti-epidemic equipment are also inseparable from international cooperation.
At the service trade fair site, throat swab sampling robots, automatic blood sampling vehicles, independent imaging inspections and other equipment that can reduce cross-infection between doctors and patients were also displayed.
Among them, the “Deep Sky Eye” CT, the star product of GE Healthcare’s Beijing manufacturing base, can automatically lift the patient’s position through the AI automatic positioning system, saving 30% of the examination time for a single patient.
At the same time, it has a compartment control function to reduce the risk of doctor-patient cross infection.
The staff said that during the epidemic, this type of CT was "employed" in medical institutions such as Wuhan Leishenshan Hospital and Beijing Xiaotangshan Hospital to fight the epidemic.
"Of the CTs supplied to the world, 2 out of every 3 are produced at the production base in Beijing." Yan Hua, Chief Marketing Officer of GE Healthcare in China, said that local innovation not only serves China, but also benefits the world.
In the future, we will deepen the strategy of win-win cooperation, optimize the plan for combining peace and war, and play a better role in future epidemic prevention.
The special exhibition area also displayed the rapid detection system for the new crown virus nucleic acid, the digital epidemic prevention and control process, and the rapid monitoring and joint prevention and control platform for the new crown epidemic. The above technologies or products have played an important role in the prevention and control of the epidemic.
“When all mankind is facing a major threat to public health, no country can stand alone.” Gao Weizhong, director of the International Exchange and Cooperation Center of the National Health Commission, said that after the outbreak, China has always insisted on strengthening international cooperation and supporting international organizations to play a role and join hands. Respond to challenges.
Wang Jian, the deputy director of the center, pointed out that to establish closer health cooperation, many obstacles need to be removed. For example, in multiple dimensions such as R&D and innovation, access supervision, production and circulation, and business models, all parties need to act in concert to promote public health. , Maintain world order and promote economic development.
The current epidemic has been effectively controlled in China, but it is still spreading globally, and many countries are facing a second attack.
Itamar Grotto (Itamar Grotto), Deputy Director-General of the Israeli Ministry of Health, said that the relevant reports on the epidemic in many countries, including China, helped Israel understand the infectiousness and infectious ability of the new crown pneumonia. Responding to the epidemic.
He said that Israel is currently upgrading its nucleic acid detection technology.
The new method does not require a special laboratory, and it can be determined whether a confirmed case is within 5 to 10 minutes.
Israel is willing to work with China and other countries to develop new tools and technologies to jointly deal with COVID-19 and other diseases.
"To defeat the epidemic requires global cooperation." Gao Li, the representative of the World Health Organization in China, pointed out that as an organization that coordinates the joint actions of the international community, it is hoped that countries will strengthen international cooperation in technological innovation and policy formulation, and increase investment in the public health system. Further slow down and alleviate the global impact of new coronary pneumonia.
(Finish)